SNNAQ (Sienna Biopharmaceuticals) Total Assets: $43.49 Mil (As of Sep. 2019)


What is Sienna Biopharmaceuticals Total Assets?

Sienna Biopharmaceuticals SNNAQ -99.00% Total Assets is $43.49 Mil as of Sep. 2019.

Sienna Biopharmaceuticals's Total Assets for the quarter that ended in Sep. 2019 was $43.49 Mil.

Total Assets is connected with ROA %. Sienna Biopharmaceuticals's annualized ROA % for the quarter that ended in Sep. 2019 was -21.02%. Total Assets is also linked to Revenue through Asset Turnover. Sienna Biopharmaceuticals's Asset Turnover for the quarter that ended in Sep. 2019 was 0.00.

Sienna Biopharmaceuticals  (OTCPK:SNNAQ) Total Assets Explanation

Total Assets is connected with ROA %.

Sienna Biopharmaceuticals's annualized ROA % for the quarter that ended in Sep. 2019 is

ROA %=Net Income (Q: Sep. 2019 )/( (Total Assets (Q: Jun. 2019 )+Total Assets (Q: Sep. 2019 ))/ count )
=-15.88/( (107.625+43.492)/ 2 )
=-15.88/75.5585
=-21.02 %

Note: The Net Income data used here is four times the quarterly (Sep. 2019) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Sienna Biopharmaceuticals's Asset Turnover for the quarter that ended in Sep. 2019 is

Asset Turnover
=Revenue (Q: Sep. 2019 )/( (Total Assets (Q: Jun. 2019 )+Total Assets (Q: Sep. 2019 ))/ count )
=0/( (107.625+43.492)/ 2 )
=0/75.5585
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Sienna Biopharmaceuticals Total Assets Related Terms

Sienna Biopharmaceuticals Total Assets Historical Data

* Premium members only.

The historical data trend for Sienna Biopharmaceuticals's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sienna Biopharmaceuticals Total Assets Chart

Sienna Biopharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18
Total Assets
5.75 62.38 136.85 107.31

Sienna Biopharmaceuticals Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 124.63 107.31 115.05 107.63 43.49

Sienna Biopharmaceuticals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Sienna Biopharmaceuticals's Total Assets for the fiscal year that ended in Dec. 2018 is calculated as

Total Assets=Total Equity (A: Dec. 2018 )+Total Liabilities (A: Dec. 2018 )
=26.581+80.725
=107.31

Sienna Biopharmaceuticals's Total Assets for the quarter that ended in Sep. 2019 is calculated as

Total Assets=Total Equity (Q: Sep. 2019 )+Total Liabilities (Q: Sep. 2019 )
=23.101+20.391
=43.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $43.49 Mil mean?
Sienna Biopharmaceuticals (SNNAQ) has a Total Assets of $43.49 Mil as of Sep. 2019. The total amount of assets as recorded on a company's balance sheet. View historical data on Sienna Biopharmaceuticals and its competitors.
Is Sienna Biopharmaceuticals' Total Assets too high?
Sienna Biopharmaceuticals' current Total Assets is $43.49 Mil.
How does Sienna Biopharmaceuticals' Total Assets compare to GTHR and PPCB?
Sienna Biopharmaceuticals' Total Assets of $43.49 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Sienna Biopharmaceuticals and its competitors. Sienna Biopharmaceuticals's current Total Assets is $43.49 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sienna Biopharmaceuticals stock overvalued right now?
Sienna Biopharmaceuticals (SNNAQ) has a current Total Assets of $43.49 Mil. The current Total Assets is $43.49 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Sienna Biopharmaceuticals (SNNAQ), the current Total Assets is $43.49 Mil as of Sep. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sienna Biopharmaceuticals Business Description

Address 30699 Russell Ranch Road, Suite 140, Westlake Village, CA, USA, 91362
Sienna Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery, development, and commercialization of first-in-class, targeted, topical products in medical dermatology and aesthetics. The objective is to develop multi-asset pipeline of topical therapies that enhance the health, appearance, and quality of life of dermatology patients. The product portfolio includes SNA-120, SNA-125, and SNA-001.